[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@NovartisNews Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1075773583220244480.png) @NovartisNews Novartis News

Novartis News posts on X about novartis, longterm the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1075773583220244480/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1075773583220244480/c:line/m:interactions.svg)

- X Week XXX +198%
- X Month XXXXX -XX%
- X Months XXXXXX +105%
- X Year XXXXXX +452%

### Mentions: X [#](/creator/twitter::1075773583220244480/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1075773583220244480/c:line/m:posts_active.svg)

- X Month XX -XX%
- X Months XX +63%
- X Year XX +860%

### Followers: XXXXX [#](/creator/twitter::1075773583220244480/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1075773583220244480/c:line/m:followers.svg)

- X Week XXXXX +0.08%
- X Month XXXXX +0.02%
- X Months XXXXX +0.37%
- X Year XXXXX -XXXX%

### CreatorRank: undefined [#](/creator/twitter::1075773583220244480/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1075773583220244480/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[novartis](/topic/novartis) #16, [longterm](/topic/longterm)

**Top accounts mentioned or mentioned by**
[@usfda](/creator/undefined) [@asco](/creator/undefined) [@ehahematology](/creator/undefined) [@escardio](/creator/undefined) [@tourmalinebio](/creator/undefined) [@indrajyotia](/creator/undefined)

**Top assets mentioned**
[Novartis AG (NVS)](/topic/novartis)
### Top Social Posts
Top posts by engagements in the last XX hours

"This #SABCS25 we're advancing the conversation on #breastcancer care. From metastatic to early-stage disease we're presenting long-term data that adds to evidence across a broad range of breast cancer patients🔗 Learn more:"  
[X Link](https://x.com/NovartisNews/status/1998380107182854288)  2025-12-09T13:12Z 8947 followers, XXX engagements


"#News: Patients with primary immune thrombocytopenia experienced extended disease control in Phase III VAYHIT2 trial #NovartisNews #reimaginingmedicine #ASH25"  
[X Link](https://x.com/NovartisNews/status/1998381366682009724)  2025-12-09T13:17Z 8947 followers, XXX engagements